CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CVS Health (CVS) shares tick higher on surprise Q2 beat
August 2, 2023 6:42 AM EDTCVS Health (NYSE: CVS) shares rose modestly in pre-open trading Wednesday after a surprise beat on the top and bottom line in the second quarter and a confirming of its full year adjusted EPS, although GAAP EPS for the year was trimmed.
The pharmacy and healthcare giant reported that adjusted EPS for the quarter fell to $2.21 from $2.53 last year, but beat the consensus of $2.13.
Revenue rose 10.3% to $88.921 billion, beating the... More
